Correlation Between Jazz Pharmaceuticals and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Jazz Pharmaceuticals and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jazz Pharmaceuticals and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jazz Pharmaceuticals PLC and Larimar Therapeutics, you can compare the effects of market volatilities on Jazz Pharmaceuticals and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jazz Pharmaceuticals with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jazz Pharmaceuticals and Larimar Therapeutics.
Diversification Opportunities for Jazz Pharmaceuticals and Larimar Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Jazz and Larimar is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Jazz Pharmaceuticals PLC and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Jazz Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jazz Pharmaceuticals PLC are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Jazz Pharmaceuticals i.e., Jazz Pharmaceuticals and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Jazz Pharmaceuticals and Larimar Therapeutics
Given the investment horizon of 90 days Jazz Pharmaceuticals PLC is expected to generate 0.23 times more return on investment than Larimar Therapeutics. However, Jazz Pharmaceuticals PLC is 4.32 times less risky than Larimar Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 12,254 in Jazz Pharmaceuticals PLC on November 8, 2024 and sell it today you would lose (247.00) from holding Jazz Pharmaceuticals PLC or give up 2.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Jazz Pharmaceuticals PLC vs. Larimar Therapeutics
Performance |
| Timeline |
| Jazz Pharmaceuticals PLC |
| Larimar Therapeutics |
Jazz Pharmaceuticals and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Jazz Pharmaceuticals and Larimar Therapeutics
The main advantage of trading using opposite Jazz Pharmaceuticals and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jazz Pharmaceuticals position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Jazz Pharmaceuticals vs. Incyte | Jazz Pharmaceuticals vs. Alnylam Pharmaceuticals | Jazz Pharmaceuticals vs. United Therapeutics | Jazz Pharmaceuticals vs. Ultragenyx |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |